IP Library Granted Patent US 7,399,759
Granted Patent B2
US 7,399,759 · App. 10/488,384 · Granted Jul 15, 2008

1, 3-benzothiazinone derivatives and use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,399,759
App. No.
10/488,384
Granted
Jul 15, 2008
Kind
B2
Abstract

This invention provides a compound represented by the formula (I): wherein R 1 is a hydrogen atom, a halogen atom, hydroxy, nitro, optionally halogenated alkyl, alkoxy optionally having substituents, acyl or amino optionally having substituents; R 2 is pyridyl, furyl, thienyl, pyrrolyl, quinolyl, pyrazinyl, pyrimidinyl, pyridazinyl, indolyl, tetrahydroquinolyl or thiazolyl, each of which may have substituents; n is 1 or 2; or a salt. And this invention provides a safe pharmaceutical comprising the compound of the formula (I), which has an excellent apoptosis inhibitory effect and MIF binding effect, for preventing and/or treating heart disease, nervous degenerative disease, cerebrovascular disease, central nervous infectious disease, traumatorathy, demyelinating disease, bone and articular disease, kidney disease, liver disease, osteomyelodysplasia, AIDS, cancer, and the like.

Claims (11)

1. 3-[6-(4-Oxo-4H-1,3-benzothiazin-2-yl)-2-pyridyl]propionic acid or a salt thereof.

2. 3-[6-(7-Chloro-4-oxo-4H-1,3-benzothiazin-2-yl)-4-methyl-2-pyridyl]propionic acid or a salt thereof.

3. 3-[2-(7-Chloro-4-oxo-4H-1,3-benzothiazin-2-yl)-4-pyridyl]propionic acid or a salt thereof.

4. 3-[2-Methyl-6-(4-oxo-4H-1,3-benzothiazin-2-yl)-4-pyridyl]propionic acid or a salt thereof.

5. 3-[2-(7-Chloro-4-oxo-4H-1,3-benzothiazin-2-yl)-6-methyl-4-pyridyl]propionic acid or a salt thereof.

6. 3-[6-(7-Chloro-4-oxo-4H-1,3-benzothiazin-2-yl)-2-pyridyl]propionic acid or a salt thereof.

7. 3-[2-(4-Oxo-4H-1,3-benzothiazin-2-yl)-4-pyridyl]propionic acid or a salt thereof.

8. 2-(6-Propylsulfonyl-2-pyridyl)-4H-1,3-benzothiazin-4-one or a salt thereof.

9. 2-(6-Methylsulfonyl-2-pyridyl)-4H-1,3-benzothiazin-4-one or a salt thereof.

10. 6-(4-Oxo-4H-1,3-benzothiazin-2-yl)-2-pyridinecarboxamide or a salt thereof.

11. N-(6-Aminohexyl)-6-(4-oxo-4H-1,3-benzothiazin-2-yl)-2-pyridinecarboxamide or a salt thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2008
From: KAJINO, MASAHIRO; NAKAYAMA, YUTAKA; KAWADA, AKIRA; KIMURA, HARUHIDE; TAWARAISHI, TAISUKE
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 020771/0841 →
CHANGE OF NAME Recorded Jun 17, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 016914/0285 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2004
From: KAJINO, MASAHIRO; KAWADA, AKIRA; NAKAYAMA, YUTAKA; KIMURA, HARUHIDE
To: TAKEDA CHEMICAL INDUSTRIES LTD.
Reel/Frame 015824/0229 →